Many health and wellness stocks have faced challenges in recent years as GLP-1 weight-loss drugs like Ozempic and Wegovy ...

WeightWatchers’ stock was surging after the company emerged from bankruptcy two months after it was announced.

EXCLUSIVE: Top doctor Dr Kim Boyd says its programmes are needed 'more than ever' despite the boom in weight loss drugs.

WW International relists on Nasdaq, pivoting to menopause care with GLP-1 drugs and coaching. Click here to read an analysis ...

WeightWatchers on Tuesday named Dr. Kim Boyd as chief medical officer and said it was planning a new program to help women ...

Weight Watchers went bankrupt in May, but now it promises it's trimmed the fat off its books and is ready to rejoin the ...

An iconic weight-loss company has emerged from several months of bankruptcy with a revamped business strategy.

WW International , formerly known as WeightWatchers, is on track to exit its financial reorganization to cut $1.15 billion in debt next week as part of its bankruptcy process, the weight management ...

Fitness experts expect clients to leave their programmes as weight loss jabs become available on the NHS. Rami Mwamba spoke ...

With new leadership and a Nasdaq relisting plan, the iconic brand is betting on women’s health and weight loss drugs to stage ...

WeightWatchers appointed Dr. Kim Boyd as its chief medical officer on Tuesday. She will be the second person to ever hold the ...

The pharmaceutical giant said WeightWatchers will work with CenterWell Pharmacy to fulfill and deliver Wegovy prescriptions.